Syngen Biotech Co., Ltd. (8279) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Syngen Biotech Co., Ltd. (8279:TWSE), powered by AI.

Current Price
$97.90
Sector
Healthcare
What is the Syngen Biotech Co., Ltd. stock price forecast?

Syngen Biotech Co., Ltd. is currently trading at $97.90. View real-time AI analysis on Alpha Lenz.

What is Syngen Biotech Co., Ltd. insider trading activity?

View the latest insider trading data for Syngen Biotech Co., Ltd. on Alpha Lenz.

What is Syngen Biotech Co., Ltd.'s P/E ratio?

View Syngen Biotech Co., Ltd.'s valuation metrics on Alpha Lenz.

Syngen Biotech Co., Ltd.

TWSE · 8279
NT$97.90+2.60(+2.73%)
Ask about Syngen Biotech Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Syngen Biotech Co., Ltd.'s ROE is 11.8%. Explore profitability and growth together.

Ask for details

Company Overview

Syngen Biotech Co., Ltd. is a biotechnology company specializing in the manufacture and sale of microbial pharmaceuticals and biochemical nutrition products. Established in 1999 and headquartered in Tainan, Taiwan, the company focuses on advanced processes such as strain identification, microorganism fermentation, and purification. Its product portfolio includes active pharmaceutical ingredients, nutritional components, biological fermentation products, as well as functional foods for both human health and applications in agriculture and aquaculture. Syngen Biotech serves a critical role in the health technology sector, supplying essential raw materials and specialized solutions to food, pharmaceutical, and agritech industries. With a sizable market capitalization and consistent financial performance, the company demonstrates its importance as a supplier of biotechnological innovations that support nutrition, medical therapies, and sustainable agricultural practices.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$2.14BRevenue
0.00Shares Out
0Employees

Margins

33.87%Gross
21.47%EBITDA
15.16%Operating
15.67%Pre-Tax
12.71%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

3.44%Rev 3Yr
10.25%Rev 5Yr
-5.20%Op Inc 3Yr
4.70%Op Inc 5Yr
-5.44%Net Inc 3Yr
4.73%Net Inc 5Yr

Returns

8.86%ROA
11.78%ROE
11.10%ROIC

Financial Health

NT$275.46MCash & Cash Equivalents
NT$399.43MNet Debt
28.44%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Syngen Biotech Co., Ltd. (ticker: 8279) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 97.9 with a P/E ratio of -x and P/B of -x.

ROE is 11.78% and operating margin is 15.16%. Annual revenue is $2.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Syngen Biotech Co., Ltd. (8279) Stock Forecast 2026 $97.90 — Price, Financials & Analyst Targets | Alpha Lenz